Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Impact of Iron Deficiency on the Incidence of Postoperative Infections (CARIPO)

29. September 2022 aktualisiert von: University Hospital, Angers

Impact of Iron Deficiency on the Incidence of Postoperative Infections - CARIPO Observational Study

Iron deficiency is a common state during the perioperative period. Data from literature do not allow us to conclude on how perioperative iron deficiency influences postoperative infections occurrence. This prospective observational study aims to assessed the postoperative infections incidence according to the preoperative iron-stock status.

Studienübersicht

Detaillierte Beschreibung

Postoperative infections are one of the most common complication after surgery, involving 2 to 50% of patients according to series and representing 16% of healthcare associated infections. Postoperative infections are highly morbid and result in a significant cost for the society, by increasing the length of hospital stay for example. They also have an impact on bacterial ecology because of the use of broad-spectrum antibiotic therapy to treat nosocomial infection. The decrease of postoperative infections occurrence is a major public health challenge.

Iron deficiency, with or without iron-deficiency anemia, is also very common during the perioperative period. Its prevalence goes from 30 to 40% and even up to 60% when associated with anemia. Iron deficiency is associated with an increased morbidity and mortality. Indeed, iron is a mineral element essential for oxygen transport through hemoglobin, but also implied in cellular metabolism by its role in the electron transport chain and in the citric acid cycle in the mitochondrion. Hence, iron is essential for the proper functioning of the immune system. Iron deficiency leads to an alteration of cellular immune defenses with a decrease in neutrophils function secondary to reduced myeloperoxidase activity, an alteration of their phagocytic capacity, a decrease in the number of T lymphocytes and a weaker response to antigenic exposure, an alteration of Natural Killer lymphocytes activity and a lower interleukine-2 production by lymphocytes. Thus, iron deficiency was associated with an increased risk of sepsis in human.

According to an old cohort published in 1988, a preoperative iron deficiency (defined by ferritin ≤20 ng/L) on 448 patients who underwent abdominal surgery, was associated with an increased in postoperative infections (23 vs 5 infections, p<0,001) and with a longer hospital stay (12±4 vs 8±3 days, p<0,001). However, a recent prospective observational study (2018), regarding orthopedic elective surgery, iron deficiency was not associated with an increased perioperative morbidity nor mortality. The statistical power was limited (100 patients, whose 6 only with iron deficiency, postoperative infections are rare in elective orthopedic surgery and assessed at day 30 instead of day 90 as recommended).

Accordingly, data from literature do not allow us to conclude on how perioperative iron deficiency influences postoperative infections occurrence. Yet, patients might benefit from preoperative iron supplementation. The PREVENTT randomized controlled trial, published in October 2020, studied the impact of intravenous iron supplementation before major abdominal surgery for anemic patients. This trial found a statistically significant decrease in hospital readmission in the treatment group and a downward trend in the occurrence of postoperative infections. Similar results were highlighted in 2016 in a randomized controlled trial comparing the fate of patients according to iron supplementation or not immediately after surgery.

Those results invite to undertake further clinical studies to better characterize the impact of iron deficiency and its correction on postoperative infections occurrence.

Our first hypothesis is that preoperative iron deficiency would be associated with an increased incidence of postoperative infections after major surgery and that its correction would lessen this association.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

413

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Adult admitted to undergo elective surgery supposed to last more than an hour and who had an iron-deficiency assessment realized by blood sample as part of standard care

Beschreibung

Inclusion Criteria:

  • Adult (≥ 18 years old)
  • Iron-deficiency assessment realized by blood sample as part of standard care
  • Elective surgery supposed to last more than an hour

Exclusion Criteria:

  • Adult under tutelage
  • Emergency surgery
  • Refusal of data collection

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Patients admitted to undergo a major elective surgery
This is an observational study regarding patients admitted to undergo a major elective surgery supposed to last more than an hour. Investigators will analyzed the incidence of postoperative infections up to 90 days after surgery according to the preoperative iron status: iron deficiency (defined as a ferritin of less than 100 µg/L or <300 µg/L And TSAT<20%) or no iron deficiency

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Incidence of postoperative infectious complication
Zeitfenster: 90 days

The main goal of this study is to compare the incidence of postoperative infectious complications according to the preoperative patient's iron-stock status (supplemented or not). The primary outcome is the occurrence of at least one infection complication within 90 days after surgery.

The various infections recorded are defined by the Center for disease control and prevention and included:

  • superficial surgical site infection (within 30 days after surgery) or deep surgical site infection (within 30 days after surgery or 90 days if an implant is in place)
  • pneumonia
  • urinary infection
  • bacteriemia
  • catheter infection
90 days

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
To assess the prevalence of preoperative iron deficiency according to the surgical field
Zeitfenster: Preoperative
Preoperative
To assess the incidence of postoperative infections according to the type of surgery
Zeitfenster: 90 days

The various infections recorded are defined by the Center for disease control and prevention and included:

  • superficial surgical site infection (within 30 days after surgery) or deep surgical site infection (within 30 days after surgery or 90 days if an implant is in place)
  • pneumonia
  • urinary infection
  • bacteriemia
  • catheter infection
90 days
To assess the incidence of overall postoperative complications according to the iron-stock status
Zeitfenster: 90 days
Postoperative complications are assessed by the POMS (Postoperative Morbidity Survey)
90 days

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

3. November 2021

Primärer Abschluss (Tatsächlich)

12. August 2022

Studienabschluss (Voraussichtlich)

15. Januar 2023

Studienanmeldedaten

Zuerst eingereicht

29. Juli 2021

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

29. Juli 2021

Zuerst gepostet (Tatsächlich)

6. August 2021

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

3. Oktober 2022

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

29. September 2022

Zuletzt verifiziert

1. September 2022

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren